Evaluation of Nesfatin-1, Adropin, Irisin and Preptin Values in Patients With a History of Recurrent Pregnancy Loss
Abstract
Amaç: İrisin, nesfatin-1, adropin ve preptin hormonlarının tekrarlayan gebelik kayıpları (TGK) üzerine olan etkilerini incelemek. Materyal metod :Van Yüzüncü Yıl Üniversitesi kadın hastalıkları ve doğum kliniğinde, Ocak 2019 ve Temmuz 2020 tarihleri arasında polikliniğe başvuran TGK öyküsü olan 100 ve TGK öyküsü olmayan 104 toplamda 204 katılımcının dahil edildiği prospektif bir çalışmadır. TGK öyküsü olanlarda etiyolojik faktörler yönünden incelendikten sonra, herhangi bir faktör bulunmayan hastalar çalışmaya dahil edildi. Katılımcıların kanında irisin, nesfatin-1, adropin ve preptin düzeylerine bakıldı. Katılımcıların gravida, parite ve abort sayıları, yaş, boy, kilo, vücut kitle endeksi (VKİ), açlık kan şekeri (AKŞ) değerleri kayıt altına alındı. Bulgular: Araştırmaya TGK hikayesi olan 100, TGK hikayesi olmayan 104 kişi olmak üzere toplamda 204 katılımcı dahil edildi. Kan örneklemesi yapılan katılıcımların 48.5%'i (n: 99) gebeyken 51.5%'i (n: 105) gebe değildi. Gebelerde irisin (ortanca 827.9'a karşı 832.7, P < 0.0001) düzeyleri TGK olmayan ve örnekleme sırasında gebe olan olgularda anlamlı şekilde yüksek izlendi. Nesfatin-1 (ortalama: -1044, %95 güven aralığı: -1150 – -938, P < 0.0001) ve preptin (ortalama: -6.0, %95 güven aralığı: -6.19 – -5.80, P < 0.0001) düzeyleri tekrarlayan gebelik kaybı olmayan ve örnekleme sırasında gebe olan olgularda anlamlı şekilde düşük izlendi. Analiz örnekleme sırasında gebe olmayan katılıcımlarda tekrarlandığı benzer bulgular irisin, adropin, nesfatin-1 ve preptin düzeyleri için P < 0.0001 anlamlılık düzeyinde tekrarlandığı izlendi. Sonuç: İrisin, nesfatin-1, preptin ve adropin hormonlarının metabolizma üzerinde farklı etkileri bulunmaktadır. Direkt ya da indirekt olarak insülin direncini (İD) etkileyerek materno-fetal glukoz homeostazını bozduğu, moleküler ve immünolojik faktörler üzerinden etki ederek, villöz trombozu indüklediği ve böylece plasental kan akışını bozduğu ya da endometriyal reseptiviteyi olumsuz etkileyerek implantasyon başarısızlığına yol açtığı düşünülmektedir. Çalışmamız; TGK öyküsü olan kadınlarla, böyle bir öyküye sahip olmayanlar karşılaştırıldığında adropin ve irisin hormon düzeylerinin istatistiksel olarak anlamlı düzeyde daha düşük olduğunu gösterirken, nesfatin-1 ve preptinin düzeylerinin daha yüksek olduğunu göstermiştir. Nesfatin-1, irisin, adropin ve preptin hormonları ve GK' ları arasındaki ilişkiyi daha net ortaya koyabilmek için; karıştırıcı faktörlerin etkisinin olmadığı, daha çok randomize kontrollü çalışmalara gerek duyulmaktadır
Objectives: To investigate the association between irisin, nesfatin-1, adropin, and preptin levels with recurrent pregnancy loss (RPL). Material and methods: A prospective study conducted between January 2019 and July 2020 in Van Yuzuncu Yil University, Department of Obstetrics and Gynecology. One hundred women with a history of RPL and 104 women without such history were included for a total of 204 participants. Women with a history of RPL without a clear etiologic factor were included in the study. Irisin, nesfatin-1, adropin, and preptin levels were determined in venous blood samples. Data on gravida, parity, age, height, weight, body-mass index, and fasting blood glucose were collected from all participants. Results: A total of 204 women, 104 with a history of RPL and 100 without a history of RPL, were included in the study. At the time of venous sampling, 48.5% of participants (n: 99) were pregnant were as 51.5% (n: 105) of them were not. Irisin levels (median: 827.9 vs 832.7, P < 0.0001) levels were higher in pregnant women without a history of RPL compared to pregnant women with a history of RPL. Nesfatin1 (mean: -1044, 95% CI: -1150 – -938, P < 0.0001) and preptin (mean: -6.0, 95% CI: -6.19 – - 5.80, P < 0.0001) levels were higher in pregnant women without an history of RPL compared to pregnant women with an history of RPL. A repeat analysis for non-pregnant women at the time of venous sampling revealed similar results for irisin, adropin, nesfatin-1 ve preptin levels at a significance level of <0.0001. Conclusion : Irisin, nesfatin-1, preptin and adropin hormones have different effects on metabolism. It disrupts materno-fetal glucose homeostasis by directly or indirectly affecting insulin resistance (ID), It disrupts materno-fetal glucose homeostasis by directly or indirectly affecting insulin resistance (ID), by acting on molecular and immunological factors, induce villous thrombosis and thus impair placental blood flow or adversely affect endometrial receptivity, leading to implantation failure. Our study showed that the hormone levels of adropin and irisin were statistically significantly lower, while nesfatin-1 and preptin levels were higher in women with a history of RPL compared to control group. In order to reveal more clearly the relationship between nesfatin-1, irisin, adropin and preptin hormones with RPL, we need randomized controlled studies without the effect of confounding factors
Objectives: To investigate the association between irisin, nesfatin-1, adropin, and preptin levels with recurrent pregnancy loss (RPL). Material and methods: A prospective study conducted between January 2019 and July 2020 in Van Yuzuncu Yil University, Department of Obstetrics and Gynecology. One hundred women with a history of RPL and 104 women without such history were included for a total of 204 participants. Women with a history of RPL without a clear etiologic factor were included in the study. Irisin, nesfatin-1, adropin, and preptin levels were determined in venous blood samples. Data on gravida, parity, age, height, weight, body-mass index, and fasting blood glucose were collected from all participants. Results: A total of 204 women, 104 with a history of RPL and 100 without a history of RPL, were included in the study. At the time of venous sampling, 48.5% of participants (n: 99) were pregnant were as 51.5% (n: 105) of them were not. Irisin levels (median: 827.9 vs 832.7, P < 0.0001) levels were higher in pregnant women without a history of RPL compared to pregnant women with a history of RPL. Nesfatin1 (mean: -1044, 95% CI: -1150 – -938, P < 0.0001) and preptin (mean: -6.0, 95% CI: -6.19 – - 5.80, P < 0.0001) levels were higher in pregnant women without an history of RPL compared to pregnant women with an history of RPL. A repeat analysis for non-pregnant women at the time of venous sampling revealed similar results for irisin, adropin, nesfatin-1 ve preptin levels at a significance level of <0.0001. Conclusion : Irisin, nesfatin-1, preptin and adropin hormones have different effects on metabolism. It disrupts materno-fetal glucose homeostasis by directly or indirectly affecting insulin resistance (ID), It disrupts materno-fetal glucose homeostasis by directly or indirectly affecting insulin resistance (ID), by acting on molecular and immunological factors, induce villous thrombosis and thus impair placental blood flow or adversely affect endometrial receptivity, leading to implantation failure. Our study showed that the hormone levels of adropin and irisin were statistically significantly lower, while nesfatin-1 and preptin levels were higher in women with a history of RPL compared to control group. In order to reveal more clearly the relationship between nesfatin-1, irisin, adropin and preptin hormones with RPL, we need randomized controlled studies without the effect of confounding factors
Description
Keywords
Kadın Hastalıkları ve Doğum, Abortus, Abortus-tekrarlayan, Adropin, Gebelik, Hormonlar, Nesfatin 1, Preptin, İrisin, Obstetrics and Gynecology, Abortion, Abortion-habitual, Adropin, Pregnancy, Hormones, Nesfatin 1, Preptin, Irisin
Turkish CoHE Thesis Center URL
WoS Q
Scopus Q
Source
Volume
Issue
Start Page
End Page
65